Comment on prognostic value of epidermal growth factor receptor mutation subtypes in surgically resected non-small cell lung cancer

被引:0
作者
Kudo, Yujin [1 ]
Shimada, Yoshihisa [1 ]
Saji, Hisashi [1 ,2 ]
Ikeda, Norihiko [1 ]
机构
[1] Tokyo Med Univ, Dept Thorac Surg, Tokyo, Japan
[2] St Marianna Univ, Sch Med, Dept Chest Surg, Kawasaki, Kanagawa, Japan
关键词
TYROSINE KINASE INHIBITOR; PULMONARY ADENOCARCINOMA; GENE-MUTATIONS; EGFR; KRAS; CHEMOTHERAPY; RECURRENCE; ERLOTINIB; SURVIVAL; IMPACT;
D O I
10.21037/jtd.2017.03.62
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页码:E499 / E502
页数:4
相关论文
共 21 条
[1]  
[Anonymous], ASIA PAC J CLIN ONCO
[2]   Kinetic analysis of epidermal growth factor receptor somatic mutant proteins shows increased sensitivity to the epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib [J].
Carey, Kendall D. ;
Garton, Andrew J. ;
Romero, Maria S. ;
Kahler, Jennifer ;
Thomson, Stuart ;
Ross, Sarajane ;
Park, Frances ;
Haley, John D. ;
Gibson, Neil ;
Sliwkowski, Mark X. .
CANCER RESEARCH, 2006, 66 (16) :8163-8171
[3]   Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib [J].
Eberhard, DA ;
Johnson, BE ;
Amler, LC ;
Goddard, AD ;
Heldens, SL ;
Herbst, RS ;
Ince, WL ;
Jänne, PA ;
Januario, T ;
Johnson, DH ;
Klein, P ;
Miller, VA ;
Ostland, MA ;
Ramies, DA ;
Sebisanovic, D ;
Stinson, JA ;
Zhang, YR ;
Seshagiri, S ;
Hillan, KJ .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) :5900-5909
[4]   Epidermal Growth Factor Receptor Mutations and Prognosis in Pathologic N1-N2 Pulmonary Adenocarcinoma [J].
Isaka, Tetsuya ;
Nakayama, Haruhiko ;
Yokose, Tomoyuki ;
Ito, Hiroyuki ;
Miyagi, Yohei ;
Matsuzaki, Tomohiko ;
Nagata, Masashi ;
Furumoto, Hideyuki ;
Nishii, Teppei ;
Katayama, Kayoko ;
Yamada, Kouzo ;
Masuda, Munetaka .
ANNALS OF THORACIC SURGERY, 2016, 102 (06) :1821-1828
[5]   The Impact of EGFR Mutation Status on Outcomes in Patients With Resected Stage I Non-Small Cell Lung Cancers [J].
Izar, Benjamin ;
Sequist, Lecia ;
Lee, Mihan ;
Muzikansky, Alona ;
Heist, Rebecca ;
Iafrate, John ;
Dias-Santagata, Dora ;
Mathisen, Douglas ;
Lanuti, Michael .
ANNALS OF THORACIC SURGERY, 2013, 96 (03) :962-968
[6]   Differences among lesions with exon 19, exon 21 EGFR mutations and wild types in surgically resected non-small cell lung cancer [J].
Jin, Ying ;
Chen, Ming ;
Yu, Xinmin .
SCIENTIFIC REPORTS, 2016, 6
[7]   The Presence of Mutations in Epidermal Growth Factor Receptor Gene Is Not a Prognostic Factor for Long-Term Outcome after Surgical Resection of Non-Small-Cell Lung Cancer [J].
Kim, Young Tae ;
Seong, Yong Won ;
Jung, Yoo Jin ;
Jeon, Yoon Kyung ;
Park, In Kyu ;
Kang, Chang Hyun ;
Kim, Joo Hyun .
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (02) :171-178
[8]   Prognostic Implication of EGFR, KRAS, and TP53 Gene Mutations in a Large Cohort of Japanese Patients with Surgically Treated Lung Adenocarcinoma [J].
Kosaka, Takayuki ;
Yatabe, Yasushi ;
Onozato, Ryoichi ;
Kuwano, Hiroyuki ;
Mitsudomi, Tetsuya .
JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (01) :22-29
[9]   Prognostic Factors for Survival After Recurrence in Patients With Completely Resected Lung Adenocarcinoma: Important Roles of Epidermal Growth Factor Receptor Mutation Status and the Current Staging System [J].
Kudo, Yujin ;
Shimada, Yoshihisa ;
Saji, Hisashi ;
Kato, Yasufumi ;
Yoshida, Koichi ;
Matsubayashi, Jun ;
Nagase, Seisuke ;
Kakihana, Masatoshi ;
Kajiwara, Naohiro ;
Ohira, Tatsuo ;
Nagao, Toshitaka ;
Ikeda, Norihiko .
CLINICAL LUNG CANCER, 2015, 16 (06) :E213-E221
[10]   Activating mutations within the EGFR kinase domain: a molecular predictor of disease-free survival in resected pulmonary adenocarcinoma [J].
Lee, Young Joo ;
Park, In Kyu ;
Park, Moo-Suk ;
Choi, Hye Jin ;
Cho, Byoung Chul ;
Chung, Kyung Young ;
Kim, Se Kyu ;
Chang, Joon ;
Moon, Jin Wook ;
Kim, Hoguen ;
Choi, Sung Ho ;
Kim, Joo-Hang .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (12) :1647-1654